Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Chỉ hiển thị Multimedia

Semaglutide may extend benefits in COVID-19
14 Aug 2026
bởiAudrey Abella
In a prespecified secondary analysis of the phase III FLOW trial, semaglutide reduces the risk of serious infections and COVID-19 events in individuals with type 2 diabetes (T2D) and chronic kidney disease (CKD).
Semaglutide may extend benefits in COVID-19
14 Aug 2026
Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors
06 Aug 2026
bởiStephen Padilla
Adolescents with obesity who underwent bariatric surgery (BS) show substantial and sustained improvements in BMI and cardiometabolic health, according to a study.







